Toggle navigation
PDFSEARCH.IO
Document Search Engine - browse more than 18 million documents
Sign up
Sign in
Back to Results
First Page
Meta Content
View Document Preview and Link
Introduction: Degludec and Degludec/Aspart Endocrinologic and Metabolic Drugs Advisory Committee Meeting November 8, 2012 Jean-Marc Guettier, MDCM
Add to Reading List
Open Document
File Size: 1,25 MB
Share Result on Facebook
Company
DCCT /
Novo Nordisk /
/
IndustryTerm
diabetes products /
insulin products /
injectable insulin product /
injectable insulin products /
/
MedicalCondition
nonfatal myocardial infarction /
hypertension /
diabetes mellitus /
immediately post-myocardial infarction /
microvascular disease /
stroke /
diabetes /
/
MedicalTreatment
insulin therapy /
/
Organization
New Drugs Center for Drug Evaluation /
Metabolism and Endocrinology Product Office /
Clinical Team Leader Division of Metabolism /
Degludec/Aspart Endocrinologic and Metabolic Drugs Advisory Committee /
U.S. Food and Drug Administration /
/
Person
Jean-Marc Guettier /
/
PublishedMedium
the ORIGIN /
/
SocialTag
Medicine
Peptide hormones
Recombinant proteins
Eli Lilly and Company
Insulin therapy
Insulin glargine
Diabetes management
Diabetes mellitus type 1
Insulin
Diabetes